Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/13/24
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 04/15/25
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 04/15/25
End: 12/30/25
Due: 12/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers | NCT06082323 | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | user2@example.com | None | 2024-06-13 | 2025-06-01 | 2026-06-01 | - | - | 2025-07-14 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis | NCT06931990 | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | user2@example.com | None | 2025-04-15 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa | NCT06932003 | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | user2@example.com | None | 2025-04-15 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |